Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.775 USD | +1.65% | +5.11% | +11.00% |
05/04 | Arbutus Biopharma Obtains Favorable Court Order in Moderna Patent Lawsuit | MT |
04/04 | Moderna Suffers Setback in Lawsuit by Arbutus | MT |
Sales 2024 * | 12.63M 9.25M 772M | Sales 2025 * | 13.59M 9.96M 831M | Capitalization | 673M 493M 41.15B |
---|---|---|---|---|---|
Net income 2024 * | -113M -82.78M -6.91B | Net income 2025 * | -130M -95.23M -7.95B | EV / Sales 2024 * | 53.3 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 49.5 x |
P/E ratio 2024 * |
-6.18
x | P/E ratio 2025 * |
-5.2
x | Employees | 73 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 76.66% |
Latest transcript on Arbutus Biopharma Corporation
1 day | +1.65% | ||
1 week | +5.11% | ||
Current month | +7.56% | ||
1 month | +8.40% | ||
3 months | +9.25% | ||
6 months | +55.90% | ||
Current year | +11.00% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 49 | 01/14/01 | |
David Hastings
DFI | Director of Finance/CFO | 62 | 11/18/11 |
Karen Sims
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 68 | 01/14/01 | |
James Meyers
BRD | Director/Board Member | 58 | 23/18/23 |
Daniel Burgess
BRD | Director/Board Member | 62 | 23/17/23 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.03% | 0 M€ | 0.00% | - | |
0.03% | 0 M€ | 0.00% | - | |
0.03% | 2 M€ | -.--% | ||
0.02% | 7 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
29/24/29 | 2.775 | +1.65% | 132 817 |
26/24/26 | 2.73 | +0.37% | 406,742 |
25/24/25 | 2.72 | -1.09% | 323,341 |
24/24/24 | 2.75 | 0.00% | 348,057 |
23/24/23 | 2.75 | +4.17% | 1,089,465 |
Delayed Quote Nasdaq, April 29, 2024 at 09:12 pm IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.00% | 492M | |
-4.06% | 86.13B | |
+1.32% | 39.82B | |
+56.59% | 25.23B | |
-14.88% | 15.36B | |
-9.14% | 11.95B | |
-16.04% | 11.6B | |
-43.00% | 11.51B | |
+6.14% | 8.71B | |
-7.02% | 8.12B |
- Stock Market
- Equities
- ABUS Stock